Change in Reward System Activation and Gut Microbiota Following RYGB and Sleeve Gastrectomy for Weight Loss vs. Control-Heads Up Ancillary

NCT ID: NCT02735564

Last Updated: 2020-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bariatric surgery is considered an effective long-term intervention for the treatment of obesity and associated complications. While bariatric surgery has been shown to result in a large sustained weight loss, the degree of weight loss and maintenance thereafter varies greatly. The Heads Up Surgical Demonstration Project (Heads Up) is a 5 year project examining weight loss after an intensive medical intervention (IMI) and the 2 most widely used bariatric surgeries (roux-en-y gastric bypass or RYGB and sleeve gastrectomy or SG). Baseline data are collected prior to surgery and follow-up data are collected at 6 months and annually thereafter. A recent meta-analysis revealed that RYGB resulted in greater weight loss and is more effective in resolving obesity related comorbidities than SG, although SG has been shown to result in a reduction of perioperative complications and reoperations1. Full elucidation of the mechanisms leading to variation in success for weight loss interventions is crucial to understanding the most effective and reliable treatments for obesity and associated comorbidities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bariatric Surgery Candidate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RYGB

Bariatric Surgery:Roux-en-y

Group Type EXPERIMENTAL

Bariatric Surgery

Intervention Type PROCEDURE

SG

Bariatric Surgery: Sleeve Gastrectomy

Group Type EXPERIMENTAL

Bariatric Surgery

Intervention Type PROCEDURE

Control

BMI matched control

Group Type PLACEBO_COMPARATOR

Bariatric Surgery

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bariatric Surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals who qualify for Heads Up and would like to participate in this ancillary study
* Be willing to participate in additional procedures including: 4 brains scans (2 before surgery and 2 after surgery), 2 meal challenges (1 before surgery and 1 after surgery), and 2 microbiota collections (1 before surgery and 1 after surgery).
* Be willing to archive microbiota samples

Control Group:


* Males and females age 21-70 years
* Body Mass Index ≥40 kg/m2 without type 2 diabetes or ≥35 kg/m2 and ≤ 60kg/m² with type 2 diabetes
* Agree to receive frequent contacts from investigators and communicate with program staff for up to 6 months
* Able to give written informed consent
* Able to comply with study procedures

Exclusion Criteria

* Unable or unwilling to give informed consent
* Pregnant or planning on becoming pregnant during the 6 months you participate in the study
* History or presence of unremoveable metal objects (medical or dental) or electronic devices or other contraindication to MRI scanning.
* Unwillingness to complete an MRI due to confined space or other related phobias


* Unable or unwilling to give informed consent
* Hospitalization for psychiatric illness or substance use/abuse within the past year
* Diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, or personality disorder as determined by the medical staff
* Travel plans that do not permit participation
* Pregnant or planning on becoming pregnant during the 6 months you participate in the study
* History of prior bariatric surgery, extensive bowel resection, or hiatal hernia repair (unless approved by the medical staff)
* History of eating disorder such as anorexia nervosa, bulimia, or binge eating (unless approved by program staff)
* Current major depressive episode or history of suicidal behaviors
* Severe congestive heart failure (NYHA class III, IV)
* Second degree or greater heart block
* Other medical, psychiatric, or behavioral limitations that in the judgement of the investigator may interfere with program participation or the ability to follow the intervention protocol
* History or presence of unremoveable metal objects (medical or dental) or electronic devices or other contraindication to MRI scanning.
* Unwillingness to complete an MRI due to confined space or other related phobias
Minimum Eligible Age

21 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pennington Biomedical Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Corby K. Martin

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Keely Hawkins, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Pennington Biomedical Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PBRC 2015-064

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

GLP1-imaging Before and After Bariatric Surgery
NCT03182231 UNKNOWN PHASE1/PHASE2